Clinical trial
Treatment for Blood Clots in the Veins of the Legs
NCT00001713 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00001713 |
|---|---|
| Title | Treatment for Blood Clots in the Veins of the Legs |
| Official title | Treatment of Acute Deep Vein Thrombosis of the Lower Extremity With Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Embolism, Thrombophlebitis |
| Intervention type | Drug |
| Interventions | Recombinant Tissue Plasminogen Activator, Heparin, Warfarin |
| Enrollment | 20 |
| Start date | Feb 1, 1998 |
| Completion | Jan 1, 2006 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: